Results 141 to 150 of about 85,545 (297)
Subcutaneous Levodopa in Parkinson's Disease: A Systematic Review and Meta‐Analysis
ABSTRACT Background Many Parkinson's disease patients receiving oral levodopa/carbidopa experience a troublesome wearing off effect. Higher doses to mitigate OFF‐time are limited by adverse effects occurring at peak dopamine levels, particularly dyskinesia.
Matthew Burton +6 more
wiley +1 more source
Macià Buades-Rotger,1,2 David Gallardo-Pujol1,3 1Department of Personality, Faculty of Psychology, University of Barcelona, Barcelona, Spain; 2Department of Neurology, University of Lübeck, Lübeck, Germany; 3Institute for Brain ...
Buades-Rotger M, Gallardo-Pujol D
doaj
Therapeutic targeting of chromatin alterations in leukemia and solid tumors
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner +7 more
wiley +1 more source
A functional polymorphism in the promoter of monoamine oxidase A gene and bipolar affective disorder [PDF]
George Kirov +5 more
openalex +1 more source
ANTICONVULSANT PROPERTIES OF SOME NEWER MONOAMINE OXIDASE INHIBITORS
R. P. Kohli +3 more
openalex +1 more source
EFFECT OF SODIUM NITRITE ON MONOAMINE OXIDASE ACTIVITY IN RAT LIVER AND BRAIN
Toru Egashira +4 more
openalex +1 more source
The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline‐preferring receptors [PDF]
Regina Alemany +2 more
openalex +1 more source

